Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients

Outcomes4Me125 enrolled

Overview

This study aims to investigate the role of a mobile health app, Outcomes4Me, in the navigation of care for people with breast cancer.

This protocol is a single arm pilot study of a novel breast cancer navigation app that is intended to assist patients with breast cancer understand their diagnosis and treatment options (both as part of standard of care practice and clinical trials) and manage their care, through treatment and symptom tracking. Patients will also be able to share information and get news via the app relevant to their cancer subtype. Results from this intervention will inform future clinical integration efforts, improve patient-centeredness of such an app-based health content and data platform, and inform the design of a larger, randomized study to demonstrate an improvement in patients' outcomes as well as enhanced Real-World Evidence (RWE) data collection.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

125

Conditions

Breast Cancer Invasive Breast Cancer Metastatic Breast Cancer Breast Carcinoma Metastatic Breast Carcinoma

Interventions

Outcomes4Me Mobile AppDEVICE

A mobile app that provides patient navigation and treatment and clinical trial options to people with breast cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older, with histologically or cytologically confirmed invasive breast cancer stage I-IV * Must be on, or planning to be on within 4 weeks of registration, active therapy, with the intent to receive some element of active therapy \> 28 days after registration * Must be able to understand, read, and write in English and be able to sign informed consent * Must have an Apple or Android smart phone that they are able to use and download the Outcomes4Me app on * Must have the ability to access the internet at least once per week via their smart phone (having a computer is not required) Exclusion Criteria: * Participations seen for consultation opinion only and are not planning to receive some element of active treatment from an MGH medical or radiation oncology provider at MGH (Boston or Waltham sites) during the 12-week study period

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States

RECRUITING

Outcomes

Primary Outcomes

Measure # of times a patient logs into the Outcomes4Me app over a 12 week period

We will track engagement with the app by tracking the number of times a user logs in to the Outcomes4Me app over a 12 week period. The app will be considered feasible if at least 40% of enrolled patients engage with the Outcomes4Me app at least 3 times during the 12-week study period.

Time frame: 12 Weeks

Secondary Outcomes

Measure System-Usability Score (SUS) of app usage

Usability will be assessed using the System Usability Scale (SUS). We wil collect the input of breast cancer patients to the SUS questions, using in-app surveys and will calculate the SUS score. We will assess overall satisfaction with the app by asking users to provide an answer to the question "How likely are you to recommend this product to a friend" on a scale of 0-10.

Time frame: 12 weeks

Measure Net-Promoter Score (NPS) of app usage

Time frame: 12 weeks

Central Contacts

Amanda Stroiney

CONTACT

860-916-4075 amanda@outcomes4me.com

Maya Said, Sci.D

CONTACT

617-794-4963

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.